JPRN-UMIN000013507已完成2 期
Randomized, double-blind, placebo-controlled study to evaluate the efficacy of levetiracetam on overcoming neurological deterioration occurring in patients with poor-grade subarachnoid hemorrhage - LEV-SAH
Department of Neurosurgery, Tohoku Graduate School of Medicine0 个研究点目标入组 80 人开始时间: 2014年4月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional,observational
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)A patient who had other neurological disorders before the onset, including epilepsy, cerebral infarction, intracerebral hemorrhage, intracranial tumor, traumatic or brain injury. 2)A patient with an expected survival of less than 1 year 3)A patient with serious renal disorder (eGFR < 40) 4)A patient with serious allergy/hypersensitivity to pyrrolidones 5)A patient whom the investigator considers to be ineligible as a subject
研究者
相似试验
进行中（未招募）
1 期
Study to assess the efficacy of homeopathic 2LALERG on symptoms of allergy to grass pollePatients: Allergic Rhinitis and allergic rhinoconjunctivitis in patients with seasonal allergy to grass pollenEUCTR2016-000097-38-BEabo'Life
未知
3 期
Phase III study on FPF1100NW monotherapyEarly Parkinson's diseaseJPRN-jRCT2080221909FP Pharmaceutical Corp.280
进行中（未招募）
1 期
Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of cyclosporine mucoadhesive gel at two different concentrations in the topical treatment of oral lichen planus in the oral mucosa.oral lichen planusEUCTR2017-000791-29-ESClínica Universidad de Navarra/Universidad de Navarra28
已完成
3 期
A clinical trial to compare the effects of riboflavin and propranolol in preventive therapy of migraineCTRI/2010/091/000539Dr. Y K Gupta120
已完成
不适用
Randomized, double-blind, placebo-controlled study of the tolerability and pharmacokinetics of ascending single (TDU6964) and 14-day repeated (TDR6966) oral doses of SAR501788 and pilot food variability evaluation (FED6965) in healthy young male subjects - Tolerability and pharmacokinetics of 14-day repeated oral doses of SAR501788 in healthy elderly male and female subjects (TDR6967)neuropathies nerve pain10034606NL-OMON32736Sanofi-aventis152